Ritazral Hynidate 5mg Tablet
By Ritazral Hynidate
Rx
10 Tablet in a Strip

Composition
Methylphenidate(5mg)

Manufacturer - Taj Pharma India Ltd
first floor, 15-6-108 afzal gunj, hyderabad, telangana 500012

Expires on or after
August, 2025

liver
Consult your doctor for advice on the use of Ritazral Hynidate 5mg Tablet if you have liver disease. Limited information is available regarding the safety of this medication in patients with liver issues. It is crucial to seek personalized guidance from a healthcare professional to ensure the appropriate and safe use of this medicine in such cases.

kidney
Limited information available on using Ritazral Hynidate 5mg Tablet in kidney disease patients. Consult doctor. Exercise caution in those with kidney issues.

alcohol
When taking Ritazral Hynidate 5mg Tablet, be cautious as it can cause extreme drowsiness when consumed with alcohol.

driving
When taking Ritazral Hynidate 5mg Tablet, be cautious while driving as it may cause dizziness, problems with focus, or blurred vision which can impact your ability to drive safely.

pregnancy
Ritazral Hynidate 5mg Tablet may not be safe during pregnancy. Animal studies indicate potential harm to the fetus. Your doctor will assess the risks and benefits before prescribing. Please consult your doctor before use.

breastfeeding
During breastfeeding, it is advised to be cautious when using Ritazral Hynidate 5mg Tablet as it could potentially harm the baby by passing into breastmilk. Limited human data is available regarding its safety during this time.
Habit Forming | Yes |
Chemical Class | Aralkylamines Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Sympthatomimmetics-ADHD |
₹79
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025